EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel compound DBZ alleviates chronic inflammatory pain and anxiety-like behaviors by targeting the JAK2-STAT3 signaling pathway

Bao Sun, Mengyao Wu, Yilin Ru, Yaxi Meng, Xin Zhang, Fengyun Wang, Zhaodi Xia, Le Yang, Yufei Zhai, Gufeng Li, Jinming Hu, Bing Qi und 5 weitere

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Bao Sun und 16 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Nort…. Hauptthemen laut MEDLINE: Janus Kinase 2, Signal Transduction, STAT3 Transcription Factor, Anxiety. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Basic Research Program of Shaanxi Province, Xi'an Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain profoundly disrupts patients' daily lives and places a heavy burden on their families. Tanshinol Borneol Ester (DBZ), a novel synthetic derivative, has demonstrated anti-inflammatory and anti-atherosclerotic effects, yet its impact on the central nervous system remains largely unexplored. This study systematically examines the central nervous system effects of DBZ through a combination of in vivo, in vitro, network pharmacology, and molecular docking approaches. In vivo, we utilized a mouse model of chronic inflammation induced by complete Freund's adjuvant to evaluate DBZ's influence on pain, anxiety-like behaviors, and its modulation of inflammatory and oxidative stress markers within the anterior cingulate cortex. In vitro studies on primary mouse astrocytes assessed DBZ's effects on cell viability and inflammatory marker expression. Network pharmacology was employed to elucidate DBZ's potential molecular targets and pathways, while molecular docking provides valuable docking confirming its interactions with key components of the JAK2-STAT3 signaling pathway. Our findings demonstrate that DBZ effectively mitigates complete Freund's adjuvant-induced chronic pain and anxiety-like behaviors. It significantly suppresses astrocytes activation, reduces levels of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, and diminishes oxidative stress markers such as reactive oxygen species and malondialdehyde, while enhancing superoxide dismutase levels. Moreover, DBZ modulates excitatory synaptic proteins and the JAK2-STAT3 signaling pathway in the anterior cingulate cortex, suggesting its role in neuroprotection. These results position DBZ as a promising candidate for the treatment of chronic pain and anxiety, offering a potential foundation for the development of new therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2Signal TransductionSTAT3 Transcription FactorAnxietyChronic PainInflammationCamphanesAnimalsMiceMaleMolecular Docking SimulationAstrocytesBehavior, AnimalMice, Inbred C57BLFreund's AdjuvantOxidative Stress

Stichwörter der Autor:innen

DBZJAK2-STAT3anxietyastrocyteschronic inflammatory pain

Substanzen

Janus Kinase 2STAT3 Transcription FactorStat3 protein, mouseJak2 protein, mouseCamphanesFreund's Adjuvant

Autor:innen und Institutionen

  • College of Life Sciences, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Northwest University, Xi'an, PR, China; Department of Pharmacy, The Second…
  • College of Life Sciences, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Northwest University, Xi'an, PR, China.
  • College of Life Sciences, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Northwest University, Xi'an, PR, China; Department of Pharmacy, Xi'an Daxi…
  • Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, PR, China.
  • Department of Pharmacy, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, PR, China.
  • Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, PR, China. Electronic address: minggao@fmmu.edu.cn.

Förderung

  • Natural Science Basic Research Program of Shaanxi Province
  • Xi'an Medical University

Zitieren

APA

Sun, B., Wu, M., Ru, Y., Meng, Y., Zhang, X., Wang, F., Xia, Z., Yang, L., Zhai, Y., Li, G., Hu, J., Qi, B., Jia, P., Liao, S., Lu, H., Zhao, M., & Zheng, X. (2025). A novel compound DBZ alleviates chronic inflammatory pain and anxiety-like behaviors by targeting the JAK2-STAT3 signaling pathway. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110223

Vancouver

Sun B, Wu M, Ru Y, Meng Y, Zhang X, Wang F, et al. A novel compound DBZ alleviates chronic inflammatory pain and anxiety-like behaviors by targeting the JAK2-STAT3 signaling pathway. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110223

BibTeX
@article{Sun2025,
  author = {Sun, Bao and Wu, Mengyao and Ru, Yilin and Meng, Yaxi and Zhang, Xin and Wang, Fengyun and Xia, Zhaodi and Yang, Le and Zhai, Yufei and Li, Gufeng and Hu, Jinming and Qi, Bing and Jia, Pu and Liao, Sha and Lu, Haiyan and Zhao, Minggao and Zheng, Xiaohui},
  title = {A novel compound DBZ alleviates chronic inflammatory pain and anxiety-like behaviors by targeting the JAK2-STAT3 signaling pathway},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110223}
}
Kostenlos starten →